Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...
  • 11/4/2025NovaBridge Biosciences (I-Mab) Files for Hong Kong IPO
  • 11/4/2025Alebund Pharma's Hong Kong IPO Application Accepted
  • 11/4/2025Lupeng Pharma's Hong Kong IPO Application Accepted
  • 11/4/2025China to Include HPV Vaccines in National Immunization Program
  • 11/4/2025CStone Receives NMPA IND Approval for Phase II Trials of CS2009
  • 11/4/2025Everest Acquires Exclusive Greater China and Other Asian Country Right...
  • 11/4/2025Abbisko Begins Phase II Trial of Oral PD-L1 Inhibitor ABSK043 in Combo...
  • 11/4/2025Genscript Secures NMPA IND Clearance for Second Bispecific ADC GenSci1...
  • 10/31/2025CDE Invites Comment on Implementation Guidance for ICH Q8, Q9 and Q10 ...
  • 10/31/2025GC Cell Licenses IASO Biotech's Multiple Myeloma CAR-T Therapy for Kor...
  • 10/31/2025Haleon Gains Momentum in China as U.S. Sales Remain Weak
  • 10/31/2025China Overhauls Drug Procurement and Reimbursement Framework to Balanc...
  • 10/31/2025China Adds Novel Drugs Catalog to National BMI Talks for the First Tim...
  • 10/31/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 10/31/2025Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...
  • 10/31/2025Roche Strikes Over $1B Global Licensing Deal with Qyuns Therapeutics
  • 10/31/2025Longwood Biopharma Secures Series B+ Funding to Accelerate Innovative ...
  • 10/31/2025Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...
  • 10/31/2025Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...
  • 10/31/2025Asia Regenerative Medicine Completes Series A Funding
  • 10/31/2025NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin
  • 10/29/2025China Issues Guidelines to Strengthen Primary Care Chronic Disease Man...
  • 10/29/2025NHSA Launches Public Consultation Module for DRG Payment Grouping Plan...
  • 10/29/2025CDE Seeks Public Feedback on Draft Guidelines for Master Protocol Drug...
  • 10/29/2025CDE Issues Technical Guidance on Post-Approval Chemistry Changes for S...
  • 10/29/2025CDE Issues Guidance on Age-Friendly Design Principles for Innovative D...
  • 10/29/2025CDE Issues Guidance on Key Elements and Trial Design for Elderly Parti...
  • 10/29/2025CDE Issues Draft Guidelines on Including Geriatric Use Information in ...
  • 10/29/2025NMPA Seeks Comments on Revised GCP Draft for Drug Trials
  • Page:8/58 Total number of articles:1731: [First][<<] [6] [7] [8] [9] [10] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group